Microwave ablation of symptomatic benign thyroid nodules: Short- and long-term effects on thyroid function tests, thyroglobulin and thyroid autoantibodies.

Szczegóły
Abstrakt

Tytuł:: Microwave ablation of symptomatic benign thyroid nodules: Short- and long-term effects on thyroid function tests, thyroglobulin and thyroid autoantibodies.
Autorzy:: Erturk MS; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Cekic B; Department of Radiology, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Celik M; Division of Endocrinology and Metabolism, Department of Internal Medicine, Trakya University Medical Faculty, Edirne, Turkey.
Ucar H; Department of Clinical Biochemistry, University of Health Sciences Antalya Training and Research Hospital, Antalya, Turkey.
Źródło:: Clinical endocrinology [Clin Endocrinol (Oxf)] 2021 Apr; Vol. 94 (4), pp. 677-683. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: <2003->: Oxford : Blackwell Publishing
Original Publication: Oxford, Blackwell Scientific Publications.
MeSH Terms:: Ablation Techniques*
Microwaves*
Thyroglobulin*
Thyroid Nodule*/surgery
Autoantibodies ; Humans ; Thyroid Function Tests ; Treatment Outcome
References:: Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules. JAMA. 2018;319(9):914.
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1-133.
Torre G, Borgonovo G, Amato A, et al. Surgical management of substernal goiter: analysis of 237 patients. Am Surg. 1995;61(9):826-831. http://www.ncbi.nlm.nih.gov/pubmed/7661484.
Banks CA, Ayers CM, Hornig JD, et al. Thyroid disease and compressive symptoms. Laryngoscope. 2012;122(1):13-16.
Nixon IJ, Angelos P, Shaha AR, Rinaldo A, Williams MD, Ferlito A. Image-guided chemical and thermal ablations for thyroid disease: review of efficacy and complications. Head Neck. 2018;40(9):2103-2115.
Papini E, Gugliemi R, Pacella CM. Laser, radiofrequency, and ethanol ablation for the management of thyroid nodules. Curr Opin Endocrinol Diabetes Obes. 2016;23(5):400-406.
Feng B, Liang P, Cheng Z, et al. Ultrasound-guided percutaneous microwave ablation of benign thyroid nodules: experimental and clinical studies. Eur J Endocrinol. 2012;166(6):1031-1037.
Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am. 2012;96(2):385-403.
Heck K, Happel C, Grünwald F, Korkusuz H. Percutaneous microwave ablation of thyroid nodules: effects on thyroid function and antibodies. Int J Hyperth. 2015;31(5):560-567.
Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017;27(11):1341-1346.
Yue W, Wang S, Wang B, et al. Ultrasound guided percutaneous microwave ablation of benign thyroid nodules: safety and imaging follow-up in 222 patients. Eur J Radiol. 2013;82(1):e11-e16.
Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244-1250.
Papini E, Pacella CM, Solbiati LA, et al. Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group. Int J Hyperth. 2019;36(1):375-381.
Bernardi S, Stacul F, Michelli A, et al. 12-month efficacy of a single radiofrequency ablation on autonomously functioning thyroid nodules. Endocrine. 2017;57(3):402-408.
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199-208.
Mainini AP, Monaco C, Pescatori LC, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20(1):11-22.
Yue W-W, Wang S-R, Lu F, et al. Radiofrequency ablation vs. microwave ablation for patients with benign thyroid nodules: a propensity score matching study. Endocrine. 2017;55(2):485-495.
Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9):S199-S202.
Hocevar M, Auersperg M, Stanovnik L. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery. Eur J Surg Oncol. 1997;23(3):208-210.
Lang BHH, Woo YC, Chiu KWH. The percentage of serum thyroglobulin rise in the first-week did not predict the eventual success of high-intensity focussed ablation (HIFU) for benign thyroid nodules. Int J Hyperth. 2017;33(8):1-6.
Cakir B, Topaloglu O, Gul K, et al. Effects of percutaneous laser ablation treatment in benign solitary thyroid nodules on nodule volume, thyroglobulin and anti-thyroglobulin levels, and cytopathology of nodule in 1 yr follow-up. J Endocrinol Invest. 2006;29(10):876-884.
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005;25(suppl_1):S69-S83.
Ahmed M, Brace CL, Lee FT, Goldberg SN. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351-369.
Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199-208.
Treglia G, Trimboli P, Verburg FA, Luster M, Giovanella L. Prevalence of normal TSH value among patients with autonomously functioning thyroid nodule. Eur J Clin Invest. 2015;45(7):739-744.
Kim J, Baek JH, Lim HK, et al. 2017 Thyroid radiofrequency ablation guideline: korean society of thyroid radiology. Korean J Radiol. 2018;19(4):632.
Contributed Indexing:: Keywords: microwave ablation; thyroid function tests; thyroid hormones; thyroid nodule
Substance Nomenclature:: 0 (Autoantibodies)
9010-34-8 (Thyroglobulin)
Entry Date(s):: Date Created: 20201006 Date Completed: 20210812 Latest Revision: 20210812
Update Code:: 20240105
DOI:: 10.1111/cen.14348
PMID:: 33020965
: Czasopismo naukowe

Full Text Finder

Objective: Microwave ablation therapy has been attracting great attention due to its advantages such as low complication rate, good cosmetic results and effective nodule shrinking. Although the effect of thermal ablation therapy on the nodule volume reduction rate has been shown several studies, a limited number of papers have been reported for the effects of microwave ablation (MWA) on thyroid function tests. The aim of this study was to investigate the short- and long-term effects of MWA therapy on thyroid function tests (TFTs), thyroglobulin (Tg) and thyroid autoantibodies in euthyroid patients.
Design, Patients and Measurements: Demographic data of the patients, TFTs, Tg, thyroid autoantibodies and thyroid volume of the nodules were recorded before the procedure and follow-up. Any differences in serum thyroid hormone levels were investigated in pre-, post- and 6-month follow-up periods before and after MWA.
Results: The difference between all thyroid hormone levels at pre MWA and 24 h after MWA was statistically significant (p < .001). FT3 (4.62) pmol/L and FT4 (10.81) pmol/L median levels increased significantly (p < .001), while thyrotropin (TSH) levels decreased at 24 h after MWA (p < .001). Thyroid antibodies levels were not statistically different at 6-month (p > .05), whereas Tg levels decreased (p < .001) compared to pre MWA.
Conclusions: While no significant effect was observed at 6 month, the effect of MWA on thyroid function tests was prominent at 24 h.
(© 2020 John Wiley & Sons Ltd.)

Informacja